NGM BIOPHARMACEUTICALS INC Quarterly Depreciation in USD from Q1 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Ngm Biopharmaceuticals Inc quarterly/annual Depreciation history and growth rate from Q1 2018 to Q4 2023.
  • Ngm Biopharmaceuticals Inc Depreciation for the quarter ending December 31, 2023 was $512K, a 15.8% decline year-over-year.
  • Ngm Biopharmaceuticals Inc Depreciation for the twelve months ending December 31, 2023 was $2.22M, a 45% decline year-over-year.
  • Ngm Biopharmaceuticals Inc annual Depreciation for 2023 was $2.22M, a 45% decline from 2022.
  • Ngm Biopharmaceuticals Inc annual Depreciation for 2022 was $4.04M, a 33.7% decline from 2021.
  • Ngm Biopharmaceuticals Inc annual Depreciation for 2021 was $6.09M, a 7.11% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $2.22M $512K -$96K -15.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 $2.32M $500K -$100K -16.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $2.42M $600K -$800K -57.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $3.22M $609K -$818K -57.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $4.04M $608K -$827K -57.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 $4.86M $600K -$900K -60% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $5.76M $1.4M -$200K -12.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $5.96M $1.43M -$127K -8.17% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $6.09M $1.44M -$89K -5.84% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-11
Q3 2021 $6.18M $1.5M -$100K -6.25% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $6.28M $1.6M -$100K -5.88% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $6.38M $1.55M -$177K -10.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $6.56M $1.52M -$320K -17.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $6.88M $1.6M -$300K -15.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $7.18M $1.7M -$200K -10.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $7.38M $1.73M -$230K -11.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $7.61M $1.84M -$36K -1.92% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $7.64M $1.9M $0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $7.64M $1.9M +$200K +11.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $7.44M $1.96M +$218K +12.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $7.22M $1.88M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 $1.9M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.7M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $1.74M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.